Sort
82,697 grants matching “vaccine development”
Identification of human tumor-associated antigens
$788,196Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Maturation of human humoral immunity through repeat malaria challenges
$788,047Kim C Williamson · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2024 · AI
MAb Passive Vaccination against Acinetobacter baumannii
$788,017Brad J Spellberg · University Of Southern California · R01 · FY2023 · AI
Protective immunity to typhoid
$787,940Stephen J McSorley · University Of Connecticut Sch Of Med/Dnt · P01 · FY2015 · AI
Application of a syndemic framework to HPV and HSV infection in emergent adult men
$787,932Danielle C Ompad · New York University · R01 · FY2017 · AI
Task A05: Small animal models for cytomegalovirus and herpes simplex viruses
$787,888David Bernstein · Cincinnati Childrens Hosp Med Ctr · N01 · FY2022 · AI
ANTIBODY EFFECTOR FUNCTION IN PROTECTION AGAINST HIV-1
$787,723Scripps Research Institute · R01 · FY2005 · AI
Hydrogel-based lymphoid tissues for generation of activated human B cells and delivery in vivo
$787,654Ankur Singh · Georgia Institute Of Technology · R01 · FY2024 · AI
Immune diagnostics and vaccine targets: breast cancer antigens from mice to women
$787,633Mary L. Disis · University Of Washington · U01 · FY2009 · CA
Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
$787,601Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Translation of a highly protective tularemia vaccine to the NHP model
$787,600Karsten R.o. Hazlett · Albany Medical College · R01 · FY2025 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$787,556Walter A. Orenstein · Emory University · N01 · FY2018 · AI
Clinical Center in COPD
$787,550University Of Alabama At Birmingham · U10 · FY2003 · HL
Human Intestinal Mucosal Immune and Functional Response to S. typhi
$787,549Alessio Fasano · University Of Maryland Baltimore · U19 · FY2015 · AI
Assembly of MHC Class I Molecules in Vitro and in Vivo
$787,431Hidde L Ploegh · Whitehead Institute For Biomedical Res · R01 · FY2009 · AI
Development of a Self Inactivating, Highly Effective TB Vaccine
$787,367Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
TASK V13: DEEP ANTIBODY PROFILING FOR RSV INFECTION AND VACCINATION
$787,348Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2022 · AI
Pediatric immune set points
$787,338John S Tsang · Yale University · P01 · FY2025 · AI
Understanding DOCK8 Function in Health and Human Disease
$787,338Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
DEFINING THE INFANT IMMUNE RESPONSE TO HIV
$787,267Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2016 · AI
Development of Efficacious and Stable Nasal Vaccine Formulations
$787,200Herman F. Staats · Duke University · U01 · FY2012 · AI
CMV Subunit Vaccine in Young Women at Risk
$787,173Robert Floyd Pass · University Of Alabama At Birmingham · U01 · FY2008 · AI
Chemoprophylaxis and HIV Host Interactions
$787,145Robert M. Grant · J. David Gladstone Institutes · R01 · FY2006 · AI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$787,127James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Clinical trials employing cancer vaccine combination therapies
$787,127James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA